Romania's Diabetes Devices Market is expected to witness growth from $ 66 Mn in 2022 to $117 Mn in 2030 with a CAGR of 7.45% for the forecasted year 2022-30. The increasing number of diabetic patients and rising public knowledge of diabetes management and control are two factors that are anticipated to support the growth of the Romania diabetes devices market. The market is segmented by type and by the end user. Some key players in this market include BioSintex, PRION POCT, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche, and Dexcom.
Romania's Diabetes Devices Market is expected to witness growth from $ 66 Mn in 2022 to $117 Mn in 2030 with a CAGR of 7.45% for the forecasted year 2022-30. Romania's healthcare spending in 2021 is 6.2% of GDP, significantly less than the average for EU nations of 9.6%. Romanian healthcare in 2021 would have cost $16. $872, or $7.4 Bn. 3 per individual and 6.2 % of GDP, which is among the lowest in the EU.
Romania had a 7.4% prevalence of diabetes among adults (20-79 years) in 2021, which is less than the 10.5% global projection. This implies that 1.4 million people in Romania are diabetic. The amount of glucose in someone's blood is measured by diabetes devices. They are portable and simple to use, enabling people to frequently check their blood glucose levels and modify their diet and medication as necessary. Individuals can improve blood glucose control by making the required dietary and medication changes as a result of routinely monitoring their blood glucose levels. People with diabetes can manage their condition more easily and carry on with their everyday activities without interruptions thanks to diabetes devices like insulin pumps and CGM systems. A person's risk of developing complications like kidney disease, nerve damage, and eye disease can be decreased by effectively controlling blood glucose levels. Insulin pumps are tiny devices that are affixed to the body and deliver an ongoing supply of insulin to help control blood sugar levels. They are especially helpful for people with type 1 diabetes who need insulin treatment.
Market Growth Drivers
The increasing number of diabetic patients and rising public knowledge of diabetes management and control are two factors that are anticipated to support the growth of the Romania diabetes care devices market. On the other hand, the rapidly rising number of new product launches further supports market development. In addition, despite the rapid development of technology, the market for diabetes treatment devices in Romania is expanding considerably. The market for diabetes treatment devices in Romania is expanding quickly, in addition to numerous government initiatives and various awareness campaigns.
Market Restraints
Diabetes devices in Romania are pricey and can cause pain. Moreover, sometimes the results are not accurate on the diabetes care devices. Furthermore, some factors hamper the market development. These elements include difficulty fitting multiple devices on small bodies and uncomfortable sensor insertions. Disruptive alerts, lost signals that cause data gaps, skin sensitivity, adhesive problems, and an abundance of information produced by diabetes care devices that is difficult to interpret are other problems.
Key Players
The National Agency for Medicines and Medical Devices (ANMDM) oversees the legal environment for diabetes devices in Romania. Before diabetes devices can be marketed and sold in Romania, the ANMDM is in charge of making sure they satisfy safety and efficacy standards. The National Diabetes Program is a government programme designed to enhance diabetes management and prevention in Romania. Policies in the programme are designed to make diabetes equipment, like insulin pumps and blood glucose meters, more widely available.
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type (Revenue, USD Billion):
The market is divided into blood glucose monitoring systems, insulin delivery systems, and mobile applications for managing diabetes within the type segment. Due to its convenience, ease of use, and usefulness in providing patients and healthcare professionals with real-time insights regarding diabetic conditions for integrated diabetes management, the segment for diabetes management mobile applications is anticipated to grow at the highest rate during the forecast period. Bare-metal Stents
By End User (Revenue, USD Billion):
The diabetes market is divided into hospitals & specialty clinics and self & home care, based on the end user.
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
The market is segmented by type and by the end user.
The Romania Diabetes Devices Market is studied from 2022-2030.
BioSintex, PRION POCT, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom are the major companies operating in Romania's diabetes devices market.